The Medical Device Companies Analysis (MDCA) portfolio provides a concise yet comprehensive review of the leading players in the medical device industry. Key sections include Strategic Focus, Financial Review, Market Assessment, Product Analysis, Research & Development, Operations and Agreements. Each chapter is summarised in a forward-looking BMI View, which provides an impartial opinion on the company’s outlook.
As a set of business reports, the MDCA portfolio contains readily digestible analysis; for example, company results are contextualised with competitor information. Recently added datasets include corporate transactions, financial ratios and FDA 510(k) clearances, where available. The MDCA portfolio is well positioned to support the evaluation of competitors, partners and investment decisions within the medical device market.